Fundraising FoxKinled Holding
Family officeHong Kong · Seed–Series A · 1 people tracked
Find your way into Kinled Holding
Sign up to see every warm intro you have to Kinled Holding
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kinled Holding team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Kinled invests in deep technological innovation across three areas. In life sciences (over 50% of its portfolio) it focuses on biomedical technology, medical devices, robotics, neuromodulation, and digital healthcare. In digital technologies (25%) it backs SaaS-enabled networks and marketplaces with an emphasis on digital health. In fintech (25%) it supports embedded payments, insurance, real estate, lending, and banking. Kinled backs early-stage, often university-spun companies in Europe and the US, operating venture accelerators and acting as an active, hands-on investor. It reviews over 2,000 business plans annually, deeply diligences around 150, and typically invests in two to four companies.
Source: firm website, verified Oct 3, 2026.
Team · 1 people
from the firm's websiteWhat they invest in
from 55 of 64 portfolio companiesHealthtech ×24Biotech ×23Medical Devices ×19Fintech ×12AI & Machine Learning ×11SaaS ×10Digital Health ×8Enterprise Software ×8
HQs:United States×11United Kingdom×9Switzerland×6Austria×3Germany×1Finland×1
Who they back
founder profiles across 24 portfolio companiesFounding team size:solo founder×122 founders×53 founders×54+ founders×2
Where their founders studiedfrom 25 founders with education data
Harvard Business School ×2Massachusetts Institute of Technology ×2University of Basel ×2
What their founders studiedfrom 24 founders with field-of-study data
Engineering ×11Business & Management ×4Computer Science ×2Humanities ×2
Where their founders worked beforefrom 28 founders with career history
ETH Zurich ×2McKinsey & Company ×2
5 founders hold a PhD · 4 hold an MBA (of 28 with degree data)
Investments · 64 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 12016 · 13 dated
Orchestra BioMed develops medical device products and uses a partnership-based model, collaborating with medical device companies to commercialize them globally.
BiotechHealthtechMedical Devices
David Hochman(Founder)in
PartnerPatrick Aisher· solo GP
Co-investorsAnthro Ventures
2cureX develops IndiTreat®, a 3D functional precision medicine test that grows patient-derived cancer cells as 3D microtumors (tumoroids) from a tumor biopsy to profile drug sensitivity and guide individualized therapy selection.
BiotechHealthtechMedical Devices
Ole Thastrup(CEO, Founder and Board member)inGrith Hagel(VP Innovation, Co-Founder and Board member)Kenneth Graabek Johansen(CFO)Jacob Thastrup(CTO)in
PartnerPatrick Aisher· solo GP
Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases.
BiotechHealthtech
Laurent Nguyen(Chief Executive Officer, Board member)inPablo Villoslada(CSO)inRossella Medori(CMO)inPaul Bikard(CFO)in
PartnerPatrick Aisher· solo GP
Co-investorsAliath BioventuresAsabys PartnersLifelinkAlta Life Sciences
Aleva Neurotherapeutics develops a high-resolution neurostimulation platform that delivers targeted therapy with high selectivity.
HealthtechMedical Devices
PartnerPatrick Aisher· solo GP
Co-investorsEFung Capital
Algonist is a pre-clinical stage biotechnology company developing novel small molecule drugs to treat chronic pain without addiction risk.
BiotechHealthtechMedical DevicesVienna, AT
PartnerPatrick Aisher· solo GP
Alloy is a telehealth service that connects women in midlife and menopause with board-certified, menopause-trained doctors for treatments including hormone therapy, GLP-1 weight care, skincare, sexual health, hair and gut health.
Digital HealthFemTechWellness & FitnessNew York, US
Anne Fulenwider(Executive Officer, Director)inMonica Molenaar(Executive Officer, Director)in
BoardAlex Fiance(Director)
PartnerPatrick Aisher· solo GP
Co-investorsAmboy Street VenturesEmmeline VenturesKairos HQPACE Healthcare CapitalSkip Capital
Alte Invest offers a real estate investment strategy focused on acquiring and refurbishing high-yield residential properties in major European cities, primarily Spain, for short-term and medium-term rental income.
FintechLogistics & Supply ChainPropTechLondon, GB
PartnerPatrick Aisher· solo GP
Co-investorsnoaSiesta Ventures
Araris develops proprietary antibody-drug conjugate (ADC) linker technology that enables one-step attachment of payloads to native antibodies for targeted cancer therapy.
BiotechMedical DevicesBasel, CH
Dragan Grabulovski(Co-founder and CEO)inPhilipp Spycher(Co-founder and Chief Scientific Officer)inIsabella Attinger-Toller(Co-founder)in
PartnerPatrick Aisher· solo GP
Co-investorsPureos BioventuresredalpineSamsung VenturesVI Partnersb2venture4BIO Capital
Artiria Medical develops guidewire and access systems for neurovascular procedures, featuring the SmartGUIDE device with a dynamic, controllable tip for navigating tortuous intracerebral anatomy.
HardwareHealthtechMedical DevicesGeneva, CH
Marc Boers(Founder)in
PartnerPatrick Aisher· solo GP
Co-investorsVerve Ventures
.jpeg){kind=logo}
Bricksave is a real estate crowdfunding platform that allows investors to pool capital to access property investment opportunities globally, with minimum investments starting at $1,000.
B2B MarketplacesCrypto & Web3FintechMarketplacesPropTech
PartnerPatrick Aisher· solo GP
Co-investorsLAB VenturesGraphene VenturesSeedrs
Calyxha is a biotech company developing novel small molecule anti-inflammatory drugs for multiple inflammatory diseases.
BiotechHealthtech
PartnerPatrick Aisher· solo GP
Cebina is an early-stage biotech investor and incubator that funds and de-risks pre-company and startup drug development projects across pre-seed, seed, and Series A stages.
BiotechDeep TechHealthtechVienna, AT
Eszter Nagy(CEO, CSO & Founder)inWolfgang Friedl(Chief Operating Officer and Legal Counsel)
PartnerPatrick Aisher· solo GP
Cobee by Pluxee is an all-in-one employee benefits platform for companies that offers a wide range of benefits including meal vouchers, transportation, childcare, training, health insurance, fitness, discounts, and equipment.
Enterprise SoftwareHR TechSaaS
Borja Aranguren(Founder)inIgnacio Travesí(Founder)inDaniel Olea(Founder)Nacho Travesí(Founder)
PartnerPatrick Aisher· solo GP
Co-investorsBalderton CapitalBStartupDila CapitalNotion CapitalOctopus VenturesSeedRocket+4 more
Cornea Sense develops diagnostic technology for detecting systemic and ocular diseases through ocular hydration assessment.
BiotechDigital HealthHardwareMedical Devices
PartnerPatrick Aisher· solo GP
Co-investorsInnovestor
Curtiss Motorcycles designs and produces electric motorcycles positioned as luxury, design-focused vehicles.
ConsumerHardwareMobility & Transportation
PartnerPatrick Aisher· solo GP
PartnerPatrick Aisher· solo GP
DF Capital is a specialist bank providing commercial finance, retail finance, and savings products to consumers and small businesses across the UK and Europe.
Enterprise SoftwareFintechSaaSManchester, GB
PartnerPatrick Aisher· solo GP
Co-investorsBritish Business BankBritish Business InvestmentsWatrium
A digital healthcare venture capital firm that invests in the intersection of artificial intelligence/big data and diagnostics/therapeutics.
AI & Machine LearningDigital HealthHealthtechSector AgnosticSilicon Valley, US
PartnerPatrick Aisher· solo GP
Doctify is a UK-founded healthcare platform that collects and publishes verified patient reviews of clinicians and care providers.
Stephanie Eltz(Founder)in
PartnerPatrick Aisher· solo GP
Co-investorsAmadeus Capital PartnersBeringeaGuinness VenturesKeen Venture PartnersLifelinkAmadeus Capital SA
Eirion Thera develops therapeutics focused on aesthetic medicine and medical dermatology.
BiotechMedical Devices
PartnerPatrick Aisher· solo GP
Co-investorsScientific Health Development
Esper builds a regulatory platform that helps government agencies research, draft, and manage regulations and policies through structured workflows and publication portals.
AI & Machine LearningEnterprise SoftwareGovTech
Maleka Momand(Founder)in
PartnerPatrick Aisher· solo GP
Co-investors8VCAlumni VenturesCota CapitalGovtech FundMadrona Venture GroupStand Together Ventures Lab+2 more
Eveliqure develops a live attenuated vaccine platform for oral administration targeting Shigella and ETEC pathogens that cause diarrheal disease in travelers and populations in low- and middle-income countries.
BiotechHealthtechMedical Devices
Tamás Henics(Co-Founder and Chief Scientific Officer)Gábor Somogyi(Chief Executive Officer)
PartnerPatrick Aisher· solo GP
Co-investorsLifelinkSmartWare.techSTRT
Forta Health provides ABA (applied behavior analysis) therapy for children with autism spectrum disorder, delivered either virtually via video with board-certified BCBAs or in-home by certified RBTs with BCBA oversight.
Digital HealthHealthtechMental Health
Jonathan Roberts(Founder)in
PartnerPatrick Aisher· solo GP
Co-investorsAlumni VenturesBantam GroupBrighter CapitalEvolution VenturesFJ LabsGood Friends+8 more
Gaucho Holdings is a holding company that owns and operates wine estates, luxury hospitality properties, and consumer brands including vineyards, a luxury hotel, and leather goods retailers.
B2B MarketplacesConsumerDirect to ConsumerE-commerceMiami Beach, US
Scott L. Mathis(Founder & Leader)in
PartnerPatrick Aisher· solo GP
Herophilus develops neurological drug discovery by combining human brain models, scaled biology, and machine learning to identify and develop novel drugs for complex brain diseases.
AI & Machine LearningBiotechHealthtech
PartnerPatrick Aisher· solo GP
Co-investors515 VenturesDolby Family VenturesBoom CapitalBoom Capital Ventures
hi.health by Pliant is a cashless claims and payments platform for insurers, embedding Visa card-based payments directly into the claims process to enable real-time provider settlement, fraud prevention, and configurable spend controls.
FintechInsurTechSaaS
PartnerPatrick Aisher· solo GP
Co-investors1921 VenturesCalm/Storm VCHaymaker VenturesSpeedinvest
IndiTreat is a CE IVD-marked functional drug sensitivity test that uses patient-derived tumor organoids to guide personalized treatment decisions for metastatic colorectal cancer (mCRC) patients.
BiotechDigital HealthMedical Devices
PartnerPatrick Aisher· solo GP
KB Medical Group manufactures safety-focused medical devices including diabetes needles and insulin syringes designed to reduce needle stick injuries.
Advanced ManufacturingHealthtechMedical Devices
PartnerPatrick Aisher· solo GP
Koite Health develops patented dual-light technology for dental care and oral health treatments, offering products like Lumoral for both preventive and therapeutic use alongside a subscription tablet line.
Digital HealthHealthtechMedical DevicesNordic region, SE
PartnerPatrick Aisher· solo GP
Co-investorsGerman Media PoolInvesdor
Linxfour provides pay-per-use equipment financing for manufacturing equipment, using Industrial IoT to base payments on actual machine usage.
Advanced ManufacturingFintechIoT
PartnerPatrick Aisher· solo GP
Co-investorsSICTIC
Lopay is a payment processing platform that enables businesses to accept payments and tips through a mobile app, with team management features for scaling operations across multiple staff members.
Enterprise SoftwareFintechHardwareRetail TechSaaSUnited Kingdom, GB
PartnerPatrick Aisher· solo GP
Co-investorsBackedRedbus VenturesThe Venture Collective
Lumicell develops a fluorescence-guided intraoperative imaging technology, including its LUMISIGHT optical imaging agent, that illuminates cancerous tissue in the surgical cavity to help surgeons remove residual cancer during procedures such as lumpectomy.
BiotechHealthtechMedical DevicesNewton, US
Jorge Ferrer(Co-Inventor & Chief Scientific Officer)inW. David Lee(Co-Founder)inHoward Hechler(Executive Officer)inMarnie Curbow(Chief Commercial Officer)inJulio Rodriguez(Head of Finance)in
BoardCosimo Fiorenza(Director)
PartnerPatrick Aisher· solo GP
Co-investorsLaunchCapitalLaunch Capital
MAG-LAB provides NMR spectroscopy services combined with selective protein isotope labeling techniques to analyze protein-ligand interactions at atomic resolution for drug discovery.
BiotechDeep TechHealthtech
Wolfgang Friedl(CEO)Robert Konrat(Scientific Head)
PartnerPatrick Aisher· solo GP
PartnerPatrick Aisher· solo GP
SME financial services app providing loans, cash flow and invoice management tools.
FintechLondon, GB
PartnerPatrick Aisher· solo GP
Co-investorsAngel AcademeSie VenturesTechstars
Mytos develops automated manufacturing technology for regenerative medicines, specifically targeting the production of stem cell-derived therapies to make treatments for conditions like Parkinson's, blindness, and spinal cord injury accessible and affordable to patients.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsLondon, GB
Ali Afshar(CEO)inIgnacio Willats(Founder)inHenry Miskin(Developer)James Cunningham(Hardware Design Engineer)Jack Owen(Operations)Sam O'Mahony(Senior Electronics Engineer)
PartnerPatrick Aisher· solo GP
Co-investorsY CombinatorAcequia Capital (AceCap)Artis VenturesDeep Science VenturesEmles Venture PartnersIQ Capital+12 more
.jpeg){kind=logo}
NanoDx develops point-of-care diagnostic devices using nanowire biosensor technology to deliver rapid test results at patient locations, targeting unmet clinical needs globally.
BiotechDeep TechHealthtechMedical Devices
PartnerPatrick Aisher· solo GP
PartnerPatrick Aisher· solo GP
NRx Pharmaceuticals develops medicines for people with unmet medical needs, focused on making untreatable diseases treatable.
BiotechDigital HealthHealthtechMental HealthWilmington, US
Jonathan Javitt(Founder, Chairman & CEO)Daniel C. Javitt(Co-founder & Chair, Scientific Advisory Board)Jonathan C. Javitt, M.D., M.P.H.(Founder, Chairman & Chief Scientist; Co-CEO HOPE Therapeutics)inProf. Daniel C. Javitt, M.D., Ph.D.(Co-founder & Chair, Scientific Advisory Board)Michael Abrams(Chief Financial Officer)Kim Bennett(Chief Investment Officer)
PartnerPatrick Aisher· solo GP
Developing a digital drug to treat Alzheimer's disease.
PartnerPatrick Aisher· solo GP
Co-investorsBifCaesar Ventures
OrderPay provides order management and analytics software for food service and hospitality venues, enabling inventory tracking, refund management, and customer insights.
E-commerceFintechFoodTechRetail TechSaaS
René Batsford(Founder & CPO)in
PartnerPatrick Aisher· solo GP
PartnerPatrick Aisher· solo GP
The Worshipful Company of Paviors is a City of London livery company dedicated to promoting the skills and knowledge of the paving trade across the UK.
Construction TechImpact & Social GoodLondon, GB
PartnerPatrick Aisher· solo GP
PreComb is a Swiss biotech company developing its proprietary 3DTwin technology, which combines automated drug testing on patient-derived tumor twins with AI-guided data analysis and response prediction.
AI & Machine LearningBiotechHealthtechMedical Devices
PartnerPatrick Aisher· solo GP
Co-investorsLongeVC
Q.ANT builds photonic processors that execute non-linear operations natively in the analog domain, aimed at reducing data movement and energy use for AI and high-performance computing workloads.
AI & Machine LearningDeep TechSemiconductors
Michael Foertsch(Founder)Michael Förtsch(Founder)Michael Förtsch in(Founder)
PartnerPatrick Aisher· solo GP
Co-investorsEuropean Super Angels ClubGrazia Equity GmbHimec.xpandLEA PartnersOnsight VenturesUVC Partners+1 more
ReBio develops targeted, locally delivered therapies for ocular oncology, using its proprietary SiSu conjugate platform to program drug exposure for eye diseases.
BiotechHealthtechMedical Devices
PartnerPatrick Aisher· solo GP
Co-investorsSICTICWI Harper Group
Saba.ai offers AI-powered invoice financing that integrates into the process automation platforms used by finance teams, using a risk engine to make credit decisions and deliver working capital.
AI & Machine LearningEnterprise SoftwareFintech
PartnerPatrick Aisher· solo GP
Shield AI develops AI pilot systems for military applications including aircraft, drones, ships, satellites, and submarines.
AI & Machine LearningDefense TechSan Diego, US
Brandon Tseng(Founder)inRyan Tseng(Founder)inAndrew Reiter(Founder)inKingsley Afemikhe(Executive Officer)inGary Steele(Chief Executive Officer)in
BoardKeith Dunleavy(Director)
PartnerPatrick Aisher· solo GP
Co-investors515 Ventures645 VenturesAdvaita CapitalAF WPartnersAlpha PartnersAltra Venture+50 more
Social Snowball is a platform for managing word-of-mouth marketing, including affiliate, referral, and influencer programs, from a single place.
Creator EconomyMarketing TechSaaSFair Haven, US
Noah Tucker(Executive Officer, Director)in
PartnerPatrick Aisher· solo GP
Co-investorsDouble Down
Sonect provides digital cash and embedded payment infrastructure that connects electronic money accounts, mobile apps and physical retail locations, enabling cash-out/cash-in, business accounts, merchant wallets and white-label/open banking services.
ConsumerEnterprise SoftwareFintechRetail TechSaaSZurich, CH
PartnerPatrick Aisher· solo GP
Co-investorsFinnovista VCItalian Angels for GrowthSICTICSixThirty Ventures
Star Syringe is a medical device licensing company that transfers its auto-disable (AD) syringe and needle-safety technology, including the K4 anti-needlestick safety needle cap, to manufacturers worldwide.
HardwareHealthtechMedical Devices
Rupert Lywood(Co-founder and Chairman)
PartnerPatrick Aisher· solo GP
Braven provides AI infrastructure for reinsurers to build and automate workflows, from routine operations to transformative business models.
AI & Machine LearningInsurTech
Andrés Gutierrez(Founder)inDaniel Palacios(Founder)inCarlos Chavez(Founder)in
PartnerPatrick Aisher· solo GP
Co-investorsMGV.VCAITO CAPITALBroom VenturesCollide Capital
TAG Therapeutics develops TELOBLOCK, an antisense nucleotide therapy that inhibits the DNA damage response at short or damaged telomeres to reduce cellular senescence, targeting telomere biology disorders and age-related diseases such as idiopathic pulmonary fibrosis and bone marrow failure.
BiotechLongevityMedical DevicesMilan, IT
Fabrizio d'Adda di Fagagna(Scientific Founder)
PartnerPatrick Aisher· solo GP
Theriva Biologics is a clinical-stage company developing therapeutics for cancer and related diseases, including an oncolytic adenovirus platform (VCN-01) and enzyme-based candidates for gastrointestinal and systemic conditions (SYN-004, SYN-020).
BiotechHealthtechRockville, US
Steven A. Shallcross(Chief Executive Officer, Chief Financial Officer, Director)inJoseph Sliman(Executive Officer)Jeffrey Riley(Executive Officer, Director)inScott Tarriff(Director)
BoardJeffrey J. Kraws(Director)Jeffrey A. Wolf(Director)
PartnerPatrick Aisher· solo GP
Tivenix develops a machine-learning software platform that analyzes epigenetic signatures in blood plasma to provide non-invasive diagnosis and progression monitoring of Alzheimer's disease and other neurodegenerative diseases.
AI & Machine LearningBiotechDigital Health
Thorsten(Management Team)in
PartnerPatrick Aisher· solo GP
Unaric builds domain-specific applications for the Salesforce platform, offering tools for communications, payments, reporting, and training that turn scattered activity into structured, AI-ready data.
AI & Machine LearningEnterprise SoftwareSaaSLondon, GB
Moritz Birke(Founder)inJohn Carini(Founder)in
PartnerPatrick Aisher· solo GP
Co-investorsLocalGlobeSICTICSupermarketBalderton CapitalLatitud Ventures
HealthtechLynnfield, US
Christopher Ford(Chairman and Treasurer)Bret Siarkowski(Secretary and Chief Technology Officer)Stefano Ciampolini(Vice President)
PartnerPatrick Aisher· solo GP
Varda industrializes low Earth orbit by manufacturing pharmaceuticals and other specialized products in space, then returning them to Earth via reusable reentry capsules.
BiotechDeep TechSpace TechEl Segundo, US
Will Bruey(Founder)inDelian Asparouhov(Founder)inDaniel Marshall(Founder)Trae Stephens(Director)Josh Wolfe(Director)
PartnerPatrick Aisher· solo GP
Co-investorsAlso CapitalCaffeinated CapitalFounders FundGeneral CatalystKhosla VenturesLux Capital+36 more
_imresizer.png)
.png)
Wayflyer provides alternative financing to small businesses and ecommerce brands, assessing business performance in real time to deliver customized funding options quickly.
E-commerceFintechSaaSDublin, IE
Aidan Corbett(Founder)inJack Pierse(Founder)Jack Pierse Aidan Corbett(Founder)
PartnerPatrick Aisher· solo GP
Co-investorsCapital 49Flucas VenturesFlying Tiger CapitalKube VCLeft Lane CapitalQED Investors+9 more
.png)
Yokoy provides a travel and expense management platform for finance teams, offering features such as invoice collection, cost center management, spend controls, and VAT-ready invoicing to streamline accounting and payment processing.
AI & Machine LearningEnterprise SoftwareFintechFuture of WorkSaaSTravel & Hospitality
PartnerPatrick Aisher· solo GP
Co-investorsBalderton CapitalLeft Lane CapitalSICTICVisionaries ClubZinal Growth PartnersSequoia Capital+2 more
zai designs and handcrafts high-end skis in Switzerland using materials such as green slate, natural rubber, and its own zai'ra carbon fibre composite, and also produces complementary ski apparel.
Advanced ManufacturingConsumerHardwareSports TechAppenzell, CH
PartnerPatrick Aisher· solo GP
Co-investorsKleiner PerkinsQiming Venture PartnersSequoia Capital
Jaidev Janardana(Founder)inDavid Nicholson(Founder)Giles Andrews(Founder)James Alexander(Founder)Richard Duvall(Founder)Tim Parlett(Founder)
PartnerPatrick Aisher· solo GP
Co-investors365.fintechAugmentum CapitalAugmentum FintechBalderton CapitalBessemer Venture PartnersBlank Space Ventures+9 more
Exits · 2
1 IPOs · 1 acquisitions · showing 1Orchestra BioMedNASDAQ: OBIO
Portfolio news
latest coverage across their companiesWayflyer · help-center.wayflyer.com · Jun 23, 2026
Shield AI · finsmes.com · Apr 2, 2026
Frequently asked questions
- How many investments has Kinled Holding made?
- Kinled Holding has 64 tracked investments, 2 of which have exited.
- What stage does Kinled Holding invest at?
- Kinled Holding invests at the Seed, Series A stages.
- What sectors does Kinled Holding focus on?
- Kinled Holding focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Fintech, Healthtech, InsurTech, IoT, Longevity, Marketplaces, Medical Devices, PropTech, Quantum Computing, Robotics, SaaS.
- Where is Kinled Holding located?
- Kinled Holding is headquartered in Hong Kong, AT.
- Does Kinled Holding lead rounds?
- Yes, Kinled Holding leads investment rounds.
- Who does Kinled Holding co-invest with?
- Kinled Holding most often shares deals with SICTIC, Alumni Ventures, Balderton Capital, among 187 tracked co-investors.
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Lauder Partners, LLC is a technology-focused investment entity that invests both directly in companies and in funds (venture and other), primarily deploying the capital of Gary Lauder and his family.
MPG Fund is an early-stage venture investor backing technology startups.
Alpha Edison is an early-stage venture firm that partners with entrepreneurs using technology to unlock latent demand in markets where consumer and business behaviors are shifting.